Skip to content

Calculus VCT

2% Initial Fee Discount Until 22 March 2024

Open for 23/24 tax year

Calculus VCT

Application

Calculus VCT

Request Illustration
(FCA-regulated advisers only)

Calculus VCT

Brochure

Calculus VCT

Prospectus

Calculus VCT – Key Features

  • Minimum Investment Amount – £5,000
  • Deadline for 23/24 allotment – 4 April 2024
  • Target annual dividend – 4.5% of NAV

Please view our Calculus VCT Investor Information page for more information on AGM Results, annual reports and more.

What are VCTs?

VCTs were introduced in 1995 to encourage individuals to invest indirectly into small and growing UK trading companies, by offering a range of tax reliefs.

VCTs are listed on the London Stock Exchange. Investors are shareholders in a listed company overseen by an independent board and run by an investment manager, which in the case of Calculus VCT is Calculus Capital Ltd.

To qualify, at least 80% of a VCT’s investments must be in small, qualifying companies (with maximum gross assets of size £15 million) that are unquoted or traded on AIM.

The Calculus VCT provides immediate exposure to a diversified portfolio of around 40 entrepreneurial UK companies with high growth potential. The funds raised by the VCT will be used to provide development and scale-up capital to new investments with robust business models and to help support growth in existing portfolio companies.

Tax Reliefs

  • 30% income tax relief *
  • Capital gains on VCT shares are tax-free
  • Tax-free dividends

* Shares have to be held for at least 5 years to benefit from Income Tax relief.

It should be noted that there is no guarantee of dividend levels nor preservation of capital value.

The information given above provides only a summary of the tax benefits. The rates shown are based on current UK legislation. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future. If you are unsure of your tax situation you should seek professional advice from a qualified tax adviser.

  • 30% income tax relief *
  • Capital gains on VCT shares are tax-free
  • Tax-free dividends **

* Shares have to be held for at least 5 years to benefit from Income Tax relief.

** It should be noted that there is no guarantee of dividend levels nor preservation of capital value.

Please note, tax benefits depend on the individual circumstances of each investor and may be subject to change in the future.

Calculus backs the innovators, the experts, the game changers. We invest in entrepreneurial businesses with growth potential, across the fastest growing sectors in the UK:

Technology

The UK is Europe’s number one technology nation, having raised double the amount of VC funding of any European market in 2022*. This hotbed of entrepreneurial activity and innovation presents a strong investment opportunity.

Within technology we predominantly look for companies providing software as a service (SaaS) to an already established client base.

Healthcare

The UK healthcare sector holds the solutions to some of today’s most urgent global challenges. From fighting pandemics to creating treatments to further advance patient care, the UK’s internationally renowned private, public and academic organisations are paving the way to new scientific discoveries.

Within the healthcare sector we typically invest in diagnostics, pharmaceutical services and drug discovery companies with existing partnerships with large pharma.

Entertainment

The creative industries in the UK have grown at more than 1.5x the rate of the wider economy over the past decade**. UK creative content companies have an established track record of producing award winning, commercially successful films and television shows watched by millions worldwide.

*Tech Nation Report 2022

**www.gov.uk June 2023

Please take the time to read through the Key Risks associated with the Calculus VCT.

Find out more

We would be delighted to answer any queries you have. Please contact the Sales and Marketing team on 020 7493 4940.

Madeleine Ingram - Co-Head, Sales & Marketing – Calculus

Madeleine Ingram

Co-Head, Sales & Marketing

Francesca Rayneau - Co-Head, Sales & Marketing – Calculus

Francesca Rayneau

Co-Head, Sales & Marketing

Matthew Moynes - Sales & Marketing – Calculus

Matthew Moynes

Sales & Marketing

Oliver Warren - Sales & Marketing – Calculus

Oliver Warren

Sales & Marketing

Frank Spurway - Sales & Marketing – Calculus

Frank Spurway

Sales & Marketing